Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1173 participants.

Also called NCT02433379

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose supportive care
Phase
Not applicable
Enrolled
  • 1,173 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02433379
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Belgium, Canada, Denmark, France, Germany, Italy, Netherlands, Poland, Puerto Rico, Spain, Switzerland, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02433379. Allocation not applicable; no masking; primary purpose supportive care. Start 2015-06-09 (actual); primary completion 2019-12-06 (actual). Results posted on 2021-01-08.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction
Acronym
UNTOUCHED
Condition
Ventricular Tachycardia
Condition
Low Cardiac Output
Intervention (Device)
EMBLEM S-ICD System
Lead sponsor
Boston Scientific Corporation (class: industry)

Record details

Record id
cardio:ct-nct02433379
Content hash
506f220843fe980a8340f1e7f6bcf9944ce8a0d13d136a7112e532369024a766